Abstract
Accurate and reproducible quantification of left ventricular (LV) function is a crucial component of clinical cardiology. LV function should be assessed in each cardiac patient. Earlier, research and development of diagnostic measures concentrated on systolic LV function, because diastole was thought to be a passive process, which is now known not to be the case. However, it is still easier to evaluate systolic than diastolic function. In the physiology lab, LV function is assessed using calculations derived from pressure and volume recordings; in clinical cardiology measurement of LIV wall motion has become the usual method for routine invasive and non-invasive diagnostics (1). We distinguish between global and regional systolic function; in order to assess global systolic LV function, quantification of end-diastolic and end-systolic volumes (LVED, LVES) and ejection fraction (EF) is essential. LV volume and ejection fraction are powerful prognostic measures in patients with coronary and valvular heart disease (2).
And they shall be accounted poet kings
Who simply tell the most heart-easing things
John Keats 1795–1821
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by 2-dimensional echocardiography; American Society of Echocardiography committee on standards, subcommittee on quantification of 2-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358 – 367
White HD, Morris RM, Brown MA, Brandt PWT, Whitlick PML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival recovery from myocardial infarction. Circulation 1987; 76: 44 – 51
Cannon CP, Thompson B, McCabe et al. Predictors of non Q wave acute myocardial infarction in patients with acute ischemic syndroms. An ananlysis from the TIMI III trials. Am J Cardiol 1995; 75: 977 – 981
Cohen GC, Pietrolungo DO, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996; 27: 1753 – 60
Weyman AE,Franklin TD, Egenes KM et al. Correlation between extent of abnormal regional wall motion and myocardial infarct size in chronically infarcted dogs. Circulation 1997; 56: 72 – 78
Hoffmann R, Lethen H, Marwick T et al. Analysis of interinstitutional observer agreement in the interpretation of dobutamine stress echocardiography. J Am Coll Cardiol 19996; 27:330–336
Panza J, Laurienzo M, Curiel RV, Quyumi AA, Cannon RO. Transesophageal. dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994; 24: 1260 – 1267
Nagel E, Lehmkuhl HB, Bocksch W et al. Non-invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763 – 770
Ashburn Wl, Schelbert Hr, Verba JW Left ventricular ejection fraction — a review of several radionuclide angiographic approaches using the scintillation camera. Proc cardiovasc Dis 1978; 20: 267 – 284
Schad N. The intermittend phased injection of contrast material into the heart. Am J Roentgen 1968; 104: 464
Schad N. The intermittend phased injection of contrast material into the heart. Am J Roentgen 1968; 104: 464
Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E, Bruns DE. Improved left ventricular endocardial. border delineation and opacification with Optison, a new echocardiography contrast agent. Results of a Phase III multicenter trial. J Am Coll Cardiol 1998; 32 (3): 746 – 752
Crouse LJ, Cheirif J, Hanly DE et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol 1993; 22: 1494 – 1500
Feinstein SB, Cheirif J, Ten Cate FJ et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990; 16: 316 – 324
Grayburn PA, Weiss JL, Hakc TC et al. Phase 3 multi center trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echo cardiograms. J Am Coll Cardiol 1998; 32: 230 – 236
Mulvagh SL, Rainbird AJ, Al-Mansour HA et al. Harmonic dobutamine stress echocardiography: Does contrast make a difference in diagnostic feasability and accuracy? Circulation 1998; 12. 527
Becher H, Tiemann K, Schlosser T, Pohl C, Nanda NC, Averkiou M, Powers J, Lüderitz B. Improvement of endocardial border delineation using tissue harmonic imaging. Echocardiography 1998; 15 (5): 511 – 516
Rakowski H., Appleton C, Chan KW et al. Canadien consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996; 9: 736 – 760
van Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cordial 1995; 25 (2): 500 – 508
Lambertz H, Schumacher U, Tries HP, Stein T. Improvement of pulmonary venous flow Doppler signal after intravenous injection of Levovist. J Am Soc Echocardiogr 1997; 10: 891 – 8
Thanigaraj, S, Perez JE. Image enhancement with second generation contrast agents improve diagnostic accuracy and reduces additional testing. J Am Soc Echocardiogr 1999; 12: 366
Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994; 23: 1440 – 1443
Thanigaraj S, Schlechtman KB, Perez JE. Improved echocardiography delineation of left ventricular thrombus with use of intravenous second-generation-contrast image enhancement. J Am Soc Echocardiogr 1999; 12: 1022 – 1026
Roberto M. Lang, M.D., James Bednarz, B.S., RDCS, Victor Mor-Avi, Ph.D., Kirk T. Spencer, M.D.J Am Soc Echocardiogr 1999; 12: 871 – 5
Burns, RN. (1995). Hemodynamics. In K. J. W Taylor, P N. Burns, & P. N. T. Wells (Eds.), Clinical Applications of Doppler Ultrasound (pp. 35 – 55 ). New York: Raven Press
Bezante G, Schwarz KQ, Chen X, Bertolazzi M, Spallarosa P, Villa G, Brunelli C. Automatic LV volume and ejection fraction by contrast harmonic color Doppler imaging compared to radionuclide ventriculography Eur Heart J 1999; 3628
Caiati C, Bina A, Zedda N et al. Contrast-enhanced harmonic colour Doppler reduces variability in assessing left ventricular volumes. Eur Heart J 1998; 19 (abstract supplement): 2350
Becher H, Tiemann K, Schlief R, Nanda N. Harmonic Power Doppler Contrast Echocardiography: preliminary clinical results (1997) Echocardiography 14; 6:637–642
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Harald Becher and Peter N Burns
About this chapter
Cite this chapter
Burns, P.N., Becher, H. (2000). Assessment of Left Ventricular Function by Contrast Echo. In: Handbook of Contrast Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59748-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-59748-0_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67083-4
Online ISBN: 978-3-642-59748-0
eBook Packages: Springer Book Archive